Medications

FDA approves first pill to treat all forms of hepatitis C

Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.

Medications

FDA approves AbbVie combo hepatitis C treatment

Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

Medications

US approves pricey new pill against hepatitis C

US regulators on Friday approved Harvoni, a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments but that carries a steep price tag.

page 1 from 3